Erik C. Emerson - 16 Jan 2024 Form 4 Insider Report for Odyssey Health, Inc. (ODYY)

Reporting relationship: Chief Commerical Officer
Issuer ticker: ODYY
Reported as of: 16 Jan 2024
Net transaction value: +$3,188
SEC form: 4
Accepted by SEC: 18 Jan 2024, 17:10:09 UTC
Prior SEC filing: 02 Jan 2024
Next SEC filing: 08 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Christine M. Farrell, as Attorney-in-Fact for Erik C. Emerson

Key filing fact

Erik C. Emerson filed Form 4 for Odyssey Health, Inc. (ODYY) on 18 Jan 2024.

Key facts

This page summarizes Erik C. Emerson's Form 4 filing for Odyssey Health, Inc. (ODYY).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 18 Jan 2024, 17:10.

Change

Previous filing in this sequence was filed on 02 Jan 2024.
Current net transaction value: +$3,188.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ODYY transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $3,188
Shares: +37,500
Change %
Price: $0.0850
Shares after: 37,500
Date: 16 Jan 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 37,500
Exercise price: $0.0850
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The non-qualified stock options are granted outside the Amended and Restated 2021 Omnibus Stock Incentive Plan, vesting immediately and the exercise price is the closing price on the date of the grant, January 16, 2024.